Data Supplement from Activating <i>FGFR2–RAS–BRAF</i> Mutations in Ameloblastoma

Supplemental Methods. Immunohistochemistry staining procedure</p

Data Supplement from Activating <i>FGFR2–RAS–BRAF</i> Mutations in Ameloblastoma

Supplemental Table S1. Ameloblastoma genotypic and clinicopathologic data.</p

Data Supplement from Activating <i>FGFR2–RAS–BRAF</i> Mutations in Ameloblastoma

Supplemental Figure S2. CTNNB1 and SMARCB1 immunohistochemistry.</p

sj-pdf-1-aor-10.1177_00034894211037416 – Supplemental material for Phosphaturic Mesenchymal Tumors of the Sinonasal Area and Skull Base: Experience at a Single Institution

Supplemental material, sj-pdf-1-aor-10.1177_00034894211037416 for Phosphaturic Mesenchymal Tumors of the Sinonasal Area and Skull Base: Experience at a Single Institution by Davis P. Argersinger, Catherine T. Haring, John E. Hanks, Kevin J. Kovatch, S. Ahmed Ali, Jonathan B. McHugh, Melissa A. Pynnonen and Erin L. McKean in Annals of Otology, Rhinology & Laryngology</p

Table S2 from HPV Integration in HNSCC Correlates with Survival Outcomes, Immune Response Signatures, and Candidate Drivers

HPV gene expression levels in the 84 HNSCC tumors.</p

Table S3 from HPV Integration in HNSCC Correlates with Survival Outcomes, Immune Response Signatures, and Candidate Drivers

Network statistics for network constructed from 89 genes with/near integration events.</p

Table S1 from HPV Integration in HNSCC Correlates with Survival Outcomes, Immune Response Signatures, and Candidate Drivers

List of the human and HPV genomic locations for the 320 identified integration events.</p

Data Supplement from Activating <i>FGFR2–RAS–BRAF</i> Mutations in Ameloblastoma

Supplemental Figure S1. Sequence electropherograms and histopathology from representative cases with CTNNB1, PIK3CA, NRAS, FGFR2, SMARCB1, HRAS and SMO mutations.</p

Data Supplement from Activating <i>FGFR2–RAS–BRAF</i> Mutations in Ameloblastoma

Supplemental Table S2. Non-ameloblastoma odontogenic tumor BRAF V600E allele-specific PCR.</p

Table S4 from HPV Integration in HNSCC Correlates with Survival Outcomes, Immune Response Signatures, and Candidate Drivers

GO terms and KEGG pathways enriched for genes differentially expressed between integration-positive and integration-negative HNC tumors.</p